IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...
Abbott Laboratories is back with another collaboration in the diabetes tech space. The Abbott Park, IL-based company announced an agreement with Beta Bionics, the developer of the iLet Bionic Pancreas ...
Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's upcoming ...
Beta Bionics plans to integrate its iLet Bionic Pancreas with Abbott's upcoming dual glucose-ketone sensor for enhanced diabetes management. Beta Bionics, Inc. has announced plans to integrate its ...
Hosted on MSN
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback